Dyve Biosciences Appoints Camilla V. Simpson to Board of Directors

THOUSAND OAKS, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Dyve Biosciences, Inc. (“Dyve”), a clinical stage biotechnology company, today announced that Camilla V. Simpson has joined Dyve’s Board of Directors.

Click to view original post